|Issue 1,691: May 3, 2023
Immunize.org Pages and Handouts
Vaccine Information Statements
Immunize.org updates the standing orders template for administering pneumococcal vaccines (PCV15, PCV20, and PPSV23) to adults
Many healthcare facilities simplify vaccination through the use of standing orders. Immunize.org has made important updates to its Standing Orders for Administering Pneumococcal Vaccines (PCV15, PCV20, and PPSV23) to Adults. This is based upon updated guidance published in CDC’s 2023 Recommended Immunization Schedule for Adults. This includes the option to administer PCV20 to adults age 65 and older who completed vaccination with PCV13 and PPSV23 at least 5 years earlier.
Immunize.org’s popular Ask the Experts: Vaccine Recommendations web page was recently updated. Now is a good time to refresh your understanding with a quick review of this short section on the general topic of vaccine recommendations.
Immunize.org’s Ask the Experts main page leads you to 30 web pages on various topics with more than 1,200 common or challenging questions and answers about vaccines and their administration. Immunize.org’s team of experts includes Kelly L. Moore, MD, MPH (team lead), Carolyn B. Bridges, MD, FACP, and Iyabode Beysolow, MD, MPH.
National Nurses Week is May 6–12 and School Nurse Day is May 10; Immunize.org thanks America’s nurses for their role in delivering and advocating for vaccination
National Nurses Week runs from May 6 through May 12. May 10 is designated School Nurse Day. Immunize.org is proud to recognize all nurses and to join the National Association of School Nurses (NASN) in recognizing the dedicated school nurses who help keep schools a safe and healthful learning environment. School nurses bridge health care and education, provide care coordination, and advocate for quality student-centered care, including vaccination.
Acknowledge and celebrate school nurses as critical educators and vaccination champions by spreading the word across your social media channels today by using the SND2023 logo, social media tools, and the hashtag #SND2023 with your posts on May 10.
IZ Express keeps 54,000+ readers up to date on what’s new in vaccines each week; invite your colleagues to subscribe!
Encourage your coworkers to subscribe to IZ Express so they get all the news that matters to vaccinators in their own inbox each Wednesday. IZ Express, the weekly e-newsletter produced by Immunize.org, alerts 54,000+ readers to the week’s important vaccine developments. IZ Express also features:
Immunize.org's Clinic Tools main page compiles resources from Immunize.org, CDC, and other organizations containing practical, “how-to” information about providing vaccinations in a medical office or non-traditional setting. This page can be found by selecting the “Clinic Tools” tab in the middle of the blue banner atop every Immunize.org web page.
These recent articles convey the potential risks of vaccine-preventable diseases and the importance of vaccination.
Immunize.org Pages and Handouts
Immunize.org recently updated its 2-page handout Shingles (Zoster): Questions and Answers to incorporate information about vaccination of adults age 19 and older who are immunocompromised as a result of treatment or disease.
Immunize.org posts seven translations of handouts for parents on how to care for children after vaccinations
When possible, it is important to provide vaccine information in the language your patient prefers. Seven translations of Immunize.org's popular handout After the Shots . . . What to Do If Your Child Has Discomfort are now available for healthcare providers to print and use with patients whose preferred language is not English. Translations include:
Immunize.org updates Spanish version of “Protect Yourself from Hepatitis A and Hepatitis B . . . A Guide for Gay and Bisexual Men”
View in Spanish.
Immunize.org updated the following medical management resources. Changes include:
Back to top
Immunize.org refreshes resources on declination, questions from parents, hepatitis, and finding old records
Immunize.org recently updated five resources with light edits and the inclusion of a QR code in the footer that links to the online version of the document. Additional changes to the resources include:
IZ Express regularly summarizes Immunize.org’s new and updated educational materials. All Immunize.org materials are free to distribute. In recent weeks, Immunize.org updated these helpful materials:
Immunize.org Web Pages
Immunize.org Printable Materials for Patients
Vaccine Information Statements
With support from CDC, Immunize.org is working with partners to increase the number of Vaccine Information Statement (VIS) translations available. By providing vaccine recipients with information in a preferred language, you can increase their confidence in, and understanding of, vaccination. During March and April, VIS translations were posted in four languages: Bengali, Hmong, Pashto, and Thai.
May 19 is National Hepatitis Testing Day; use these resources to promote testing and encourage vaccination
It's Hepatitis Awareness Month across the United States, and May 19 marks National Hepatitis Testing Day. Help shed light on the burden of viral hepatitis and encourage testing and vaccination according to CDC recommendations. Key facts:
CDC continues to recommend routine hepatitis B vaccination for all infants and catch-up vaccination of children and teens younger than age 19 years.
Back to top
Immunize.org's laminated versions of the 2023 U.S. child and adolescent immunization schedule and the 2023 U.S. adult immunization schedule are in stock and shipping now. Order while supplies last. Once sold out, we will not print more until 2024.
While the schedules are available online from CDC at no cost, Immunize.org’s laminated schedules are ideal for use in any busy healthcare setting. Their tough coating can be wiped down, and they’re durable enough to stand up to a year of use.
Help Immunize.org reach more vaccinators through your social media networks. Follow us and share our posts featuring Ask the Experts questions and our clinical resources on Facebook, LinkedIn, Twitter, YouTube, and Instagram!
Immunize.org has a social media program designed to highlight our educational resources for a new audience of vaccinators. Our social media channels now feature our most popular printable resources and Ask the Experts questions, as well as announcements important to frontline vaccinators. Please view and share our newest feature, Ask the Experts videos.
Like, follow, and share Immunize.org’s social media accounts and encourage colleagues and others interested in vaccination to do likewise:
Explore the www.Give2MenACWY.org website to increase coverage for the MenACWY booster and other adolescent vaccinations
Immunize.org's www.Give2MenACWY.org website promotes the importance of adolescent vaccination, including the recommended MenACWY vaccine booster dose at age 16. Many teens are behind on vaccines because of the pandemic, so vaccine outreach is more important than ever.
The website is divided into five easy-to-access sections:
The site also categorizes materials according to whether they are primarily of interest to providers, to adolescents, or to parents.
“Effectiveness of Monovalent mRNA Vaccination in Preventing COVID-19–Associated Invasive Mechanical Ventilation and Death among Immunocompetent Adults during the Omicron Variant Period—IVY Network, 19 U.S. States, February 1, 2022—January 31, 2023” published in MMWR
CDC published Effectiveness of Monovalent mRNA Vaccination in Preventing COVID-19–Associated Invasive Mechanical Ventilation and Death among Immunocompetent Adults during the Omicron Variant Period—IVY Network, 19 U.S. States, February 1, 2022—January 31, 2023 on April 28 in MMWR. A portion of the summary appears below.
Waning of monovalent mRNA COVID-19 vaccine effectiveness against COVID-19–associated hospitalization among adults is recognized; however, little is known about the durability of protection provided by these vaccines against COVID-19–associated invasive mechanical ventilation (IMV) and in-hospital death during the Omicron variant period. . . .
Monovalent mRNA vaccination was 76% effective in preventing COVID-19–associated IMV and death <6 months after the last dose and remained 56% effective at 1–2 years. . . .
Monovalent mRNA COVID-19 vaccines provided substantial, durable protection against COVID-19–associated IMV and death. All adults should remain up to date with recommended COVID-19 vaccination to prevent critical outcomes of COVID-19.
Virtual: NFID hosts webinar titled “Advances in Preventing and Treating Respiratory Syncytial Virus (RSV)” on May 4
National Foundation of Infectious Diseases (NFID) will host a webinar titled Advances in Preventing and Treating Respiratory Syncytial Virus (RSV), 1:00–2:00 p.m. (ET) on May 4. The interactive panel discussion will focus on the latest advances in preventing and treating RSV across the lifespan.
For more upcoming events, visit our Calendar of Events.